Free Trial
OTCMKTS:EMMA

Emmaus Life Sciences 7/2/2024 Earnings Report

Emmaus Life Sciences logo
$0.02 +0.01 (+49.62%)
As of 02:11 PM Eastern

Emmaus Life Sciences EPS Results

Actual EPS
$0.02
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

Emmaus Life Sciences Revenue Results

Actual Revenue
$7.07 million
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

Emmaus Life Sciences Announcement Details

Quarter
Time
N/A
Conference Call Date
N/A
Conference Call Time
N/A

Conference Call Resources

Emmaus Life Sciences Earnings Headlines

Emmaus Life Sciences Inc
Is President Trump Lying To You With This?
President Trump’s economic transition isn’t without hardship. But what if there were a smart, tax-free way to protect your 401(k), IRA, or pension from market chaos and currency collapse? The 2025 Wealth Protection Guide reveals a legal IRS strategy that may let you keep more of your retirement—regardless of what happens next. Trump’s warning was real. So is this opportunity.
See More Emmaus Life Sciences Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Emmaus Life Sciences? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Emmaus Life Sciences and other key companies, straight to your email.

About Emmaus Life Sciences

Emmaus Life Sciences (OTCMKTS:EMMA), a commercial-stage biopharmaceutical company, discovers, develops, markets, and sells treatments and therapies primarily for rare and orphan diseases in the United States and internationally. The company's lead candidate is Endari, an L-glutamine oral powder to reduce the acute complications of sickle cell disease in adult and pediatric patients five years of age and older. It has a collaboration agreement with Kainos Medicine, Inc. for the preclinical development of Kainos' patented IRAK4 inhibitor (KM10544) as an anti-cancer drug. The company was formerly known as Emmaus Holdings, Inc. and changed its name to Emmaus Life Sciences, Inc. in September 2011. The company was founded in 2000 and is headquartered in Torrance, California.

View Emmaus Life Sciences Profile

More Earnings Resources from MarketBeat